학술논문
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
Document Type
Journal
Author
Michallet, Anne-Sophie; Quinquenel, Anne; Letestu, Remi; Magali, Tavernier; Morisset, Stephane; Aurran, Therese; Laribi, Kamel; Cymbalista, Florence; Levy, Vincent; Simon, Laurence; Weil, Damien Roos; Leblond, Veronique; Dilhuydy, Marie Sarah; Tomowiak, Cecile; Dartigeas, Caroline; Guieze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; De Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Lepretre, Stephane; Carassou, Philippe; Gay, Julie; Hivert, Benedicte; Fornecker, Luc Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahe, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loic; Khac, Florence Nguyen; Rouille, Valerie; Delmer, Alain Jacques
Source
Subject
Language
English
ISSN
15280020